Immunohistochemical correlates of TP53 somatic mutations in cancer B Murnyák, T Hortobágyi Oncotarget 7 (40), 64910, 2016 | 119 | 2016 |
Pathophysiology of meningioma growth in pregnancy T Hortobágyi, J Bencze, B Murnyák, MC Kouhsari, L Bognár, ... Open Medicine 12 (1), 195-200, 2017 | 65 | 2017 |
PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma B Murnyák, MC Kouhsari, R Hershkovitch, B Kálmán, G Marko-Varga, ... Oncotarget 8 (28), 46348-46362, 2017 | 59 | 2017 |
Epigenetics of meningiomas B Murnyák, L Bognár, Á Klekner, T Hortobágyi BioMed research international 2015 (1), 532451, 2015 | 43 | 2015 |
Assessment of candidate immunohistochemical prognostic markers of meningioma recurrence T Csonka, B Murnyák, R Szepesi, J Bencze, L Bognár, Á Klekner, ... Folia Neuropathologica 54 (2), 114-126, 2016 | 33 | 2016 |
Poly (ADP-ribose) polymerase-1 (PARP1) and p53 labelling index correlates with tumour grade in meningiomas T Csonka, B Murnyák, R Szepesi, A Kurucz, Á Klekner, T Hortobágyi Folia Neuropathologica 52 (2), 111-120, 2014 | 28 | 2014 |
GWAS meta-analysis of suicide attempt: identification of 12 genome-wide significant loci and implication of genetic risks for specific health factors AR Docherty, N Mullins, AE Ashley-Koch, X Qin, JRI Coleman, A Shabalin, ... American journal of psychiatry 180 (10), 723-738, 2023 | 27 | 2023 |
Molecular subgroups of glioblastoma–an assessment by immunohistochemical markers Á Nagy, F Garzuly, G Padányi, I Szűcs, Á Feldmann, B Murnyák, ... Pathology & Oncology Research 25, 21-31, 2019 | 23 | 2019 |
Occurrence and molecular pathology of high grade gliomas B Murnyák, T Csonka, K Hegyi, G Méhes, A Klekner, T Hortobágyi Ideggyogyaszati Szemle 66 (9-10), 312-321, 2013 | 16* | 2013 |
Identification of novel, replicable genetic risk loci for suicidal thoughts and behaviors among US military veterans NA Kimbrel, AE Ashley-Koch, XJ Qin, JH Lindquist, ME Garrett, ... JAMA psychiatry 80 (2), 135-145, 2023 | 14 | 2023 |
Association of TP53 Alteration with Tissue Specificity and Patient Outcome of IDH1-Mutant Glioma B Murnyak, LE Huang Cells 10 (8), 2116, 2021 | 12 | 2021 |
Haemorrhagic transformation in ischaemic stroke is more frequent than clinically suspected–A neuropathological study R Szepesi, Á Csokonay, B Murnyák, MC Kouhsari, G Hofgárt, L Csiba, ... Journal of the Neurological Sciences 368, 4-10, 2016 | 11 | 2016 |
Molecular pathology of meningiomas B Murnyak, T Csonka, T Hortobagyi Ideggyogyaszati Szemle 68 (9-10), 292-300, 2015 | 11 | 2015 |
The melanin-concentrating hormone system in human, rodent and avian brain J Bencze, K Pocsai, B Murnyák, PA Gergely, B Juhász, Z Szilvássy, ... Open Medicine 13 (1), 264-269, 2018 | 8 | 2018 |
Genome-wide association study meta-analysis of suicide attempt identifies twelve genome-wide significant loci and implicates genetic risks for specific health factors AR Docherty, N Mullins, AE Ashley-Koch, X Qin, JRI Coleman, A Shabalin, ... medRxiv, 2022.07. 03.22277199, 2022 | 7 | 2022 |
A melanoma és az agyi áttétképződés molekuláris háttere| Molecular background of the melanoma and the brain metastasis F Katona, B Murnyák, G Marko-Varga, T Hortobágyi Orvosi Hetilap 158 (28), 1083-1091, 2017 | 7 | 2017 |
Inclusion body myositis–pathomechanism and lessons from genetics B Murnyák, L Bodoki, M Vincze, Z Griger, T Csonka, R Szepesi, A Kurucz, ... Open Medicine 10 (1), 2015 | 7 | 2015 |
Tyrosine Kinase Inhibitor Imatinib Mesylate Alters DMBA‐Induced Early Onco/Suppressor Gene Expression with Tissue‐Specificity in Mice PA Gergely, B Murnyák, J Bencze, A Kurucz, T Varjas, K Gombos, ... BioMed Research International 2019 (1), 8670398, 2019 | 6 | 2019 |
Molecular genetics of familial tumour syndromes of the central nervous system B Murnyák, R Szepesi, T Hortobágyi Orvosi Hetilap 156 (5), 171-177, 2015 | 6 | 2015 |
Occurrence and molecular pathology of low grade gliomas B Murnyák, T Csonka, A Klekner, T Hortobágyi Ideggyogyaszati Szemle 66 (9-10), 305-311, 2013 | 6 | 2013 |